1. "Breast Medicine Service"
Formats
  1. Journal Article (2170)
  2. Meeting Abstract (1650)
  3. Review (78)
  4. Book Section (67)
  5. Editorial (42)
  6. Conference Paper (28)
  7. Guidelines (26)
  8. Correspondence (16)
  9. Miscellaneous (11)
  10. Research Letter (10)
  11. Book Whole (5)
Groups
  1. Breast Medicine Service (4103)
  2. Department of Medicine (4103)
  3. Solid Tumor Oncology Division (4103)
  4. Survivorship Research (2337)
  5. GSK Faculty (1492)
  6. Population Sciences Research Program (1339)

More Groups

People
  1. Clifford Hudis (905)
  2. Larry Norton (758)
  3. Mark Robson (676)
  4. Neal Rosen (425)
  5. Andrew Seidman (318)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (57)
  2. 2024 (192)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (802)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (169)
  4. Annals of Oncology (158)
  5. Clinical Cancer Research (128)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (853)
  2. American Association for Cancer Research (749)
  3. Springer (329)
  4. Elsevier Inc. (322)
  5. Oxford University Press (278)
  6. Nature Publishing Group (273)

More Publishers

Results (4103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Synthesis and evaluation of a library of small molecules that degrade the HER2-tyrosine kinase
    Meeting Abstract

    Chiosis, G.; Lucas, B.; Timaul, M.; Rosen, N.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • Modulation of Hsp90 function by ansamycins enhances chemotherapy induced apoptosis in breast cancer cell lines in an RB and schedule dependent manner
    Meeting Abstract

    Munster, P. N.; Basso, A. D.; Solit, D.; Norton, L.; Scher, H.; Rosen, N.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • Risk of endometrial carcinoma associated with BRCA mutation
    Meeting Abstract

    Levine, D. A.; Lin, O.; Barakat, R. R.; Robson, M. E.; Offit, K.; McDermott, D.; Cohen, L.; Satagopan, J.; Boyd, J.
    Gynecologic Oncology (2001)

    Fulltext@MSK | Save
  • Genetic analysis of ovarian carcinoma histogenesis
    Meeting Abstract

    Pothuri, B.; Leitao, M.; Barakat, R. R.; Akram, M.; Bogomolniy, F.; Olvera, N.; Lin, O.; Soslow, R.; Robson, M. E.; Offit, K.; more...
    Gynecologic Oncology (2001)

    Fulltext@MSK | Save
  • Insurance reimbursement for risk-reducing surgeries in BRCA1 and BRCA2 heterozygotes
    Meeting Abstract

    Kauff, N.; Scheuer, L.; Robson, M.; Barakat, R.; Borgen, P.; Heerdt, A.; Hudis, C.; Norton, L.; Davis, J.; Offit, K.
    Genetics in Medicine (2001)

    Fulltext@MSK | Save
  • BCL-2 antisense (G3139) plus docetaxel for treatment of progressive androgen-independent prostate cancer
    Meeting Abstract

    Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Rosen, N.; Scher, H. I.
    European Journal of Cancer (2001)

    Fulltext@MSK | Save
  • Cardiac safety and efficacy of TLC D99 (D99) and trastuzumab in patients with advanced breast cancer
    Meeting Abstract

    Theodoulou, M.; Campos, S.; Welles, L.; Batist, G.; Winer, E.; Hudis, C.
    European Journal of Cancer (2001)

    Fulltext@MSK | Save
  • Ansamycins cause a G2/M arrest in glioblastoma cell lines
    Meeting Abstract

    Martinez-Lacaci, I.; Srethapakdi, M.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Ansamycins inhibit Akt activation and induce the 20S proteasomal degradation of Akt protein
    Meeting Abstract

    Basso, A. D.; Solit, D. B.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • The tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumors
    Meeting Abstract

    Moasser, M. M.; Basso, A. D.; Averbuch, S. D.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save